We offer daily assistance for technical and scientific matters.
What is Alpha-1 Antitrypsin Deficiency (AATD)?
The AAT gene is highly polymorphic, with more than 100 described variants in addition to the normal M allele. Among these, the S and Z alleles are the most common pathogenic forms, with the Z variant associated with the most severe clinical impact in individuals with alpha‑1 antitrypsin deficiency.
People carrying the MZ or MS genotypes are generally considered carriers and are not typically at increased risk for lung or liver disease. In contrast, individuals with ZZ or SZ genotypes are classified as AAT‑deficient, presenting moderate to severe deficiency and a significantly higher risk of clinical manifestations.
Alpha‑1 Antitrypsin Deficiency (AATD) is a rare hereditary disorder characterized by reduced levels of alpha‑1 antitrypsin, which can lead to serious lung and liver disease in both children and adults.
1/2,500
individuals with European ancestory are affected by AAT deficiency
90%
remain undiagnosed
3.4
million individuals are affected by AAT deficiency
Knowledge & Science
We aim to educate and share scientific and medical educational information with our customers all around the world.
Understand in 2 minutes how capillary electrophoresis works, and why it gives such high and clear resolution in lab testing.
Instrument for diagnosing Alpha-1 Antitrypsin Deficiency
Efficiency re-dIFined.
The compact and affordable automation of Capillary Electrophoresis.
The high throughput solution for newborn hemoglobin disorders screening.
Capillary Electrophoresis solution to meet your high capacity needs.
High Throughput - Smart Automation.
A concentrate of Sebia’s expertise in a high throughput instrument.
Evolution makes the difference.
Large menu with high quality results on gel electrophoresis.
Authentically clear!
a) Slev PR, Williams BG, Harville TO, Ashwood ER, Bornhorst JA. Efficacy of the detection of the alpha1-antitrypsin "Z" deficiency variant by routine serum protein electrophoresis. Am J Clin Pathol. 2008 Oct;130(4):568-72. doi: 10.1309/JWEWE4QRQKJ5EJEU. PMID: 18794049.
b) Rahaghi FF, Sandhaus RA, Brantly ML, Rouhani F, Campos MA, Strange C, Hogarth DK, Eden E, Stocks JM, Krowka MJ, Stoller JK. The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction. COPD. 2012 Aug;9(4):352-8. doi: 10.3109/15412555.2012.669433. Epub 2012 Apr 16. Erratum in: COPD. 2013 Aug;10(4):555. Brantly, Mark L [added]; Rouhani, Farshid [added]; Campos, Michael A [added]. PMID: 22506682.
c) Greene DN, Elliott-Jelf MC, Straseski JA, Grenache DG. Facilitating the laboratory diagnosis of α1-antitrypsin deficiency. Am J Clin Pathol. 2013 Feb;139(2):184-91. doi: 10.1309/AJCP6XBK8ULZXWFP. PMID: 23355203.
d) Balduyck M, Odou MF, Zerimech F, Porchet N, Lafitte JJ, Maitre B. Diagnosis of alpha-1 antitrypsin deficiency: modalities, indications and diagnosis strategy. Rev Mal Respir. 2014 Oct;31(8):729-45. doi: 10.1016/j.rmr.2014.06.001. Epub 2014 Jul 3. PMID: 25391508.
e) Akbas N, Gonzalez G, Buffone GJ, Grenache DG, Devaraj S. A Library of Rare α1-Antitrypsin (AAT) Variant Phenotypes to Aid in the Diagnosis of AAT Deficiency. Am J Clin Pathol. 2016 Sep;146(3):289-93. doi: 10.1093/ajcp/aqw112. PMID: 27543976.
f) Franciosi AN, Carroll TP, McElvaney NG. Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians. Lancet Respir Med. 2019 Dec;7(12):1059-1067. doi: 10.1016/S2213-2600(19)30141-9. Epub 2019 Jul 16. PMID: 31324540.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.
